An Observational Study to Validate the Cumulative Life Course Impairment (CLCI) Instrument (DermCLCI-p) in Adult Participants With Moderate to Severe Chronic Plaque Psoriasis (PsO)

CompletedOBSERVATIONAL
Enrollment

154

Participants

Timeline

Start Date

November 9, 2023

Primary Completion Date

March 21, 2025

Study Completion Date

March 21, 2025

Conditions
Psoriasis
Trial Locations (16)

1070

Universite Libre de Bruxelles - Hopital Erasme /ID# 252456, Anderlecht

1200

Cliniques Universitaires UCL Saint-Luc /ID# 253234, Brussels

3000

Universitair Ziekenhuis Leuven /ID# 252457, Leuven

9000

UZ Gent /ID# 252458, Ghent

9990

Dermatologie Maldegem /ID# 252454, Maldegem

20246

Universitaetsklinikum Hamburg-Eppendorf /ID# 254340, Hamburg

37308

Gemeinschaftspraxis Dres. Anika Hünermund/Mario Pawlak /ID# 255874, Heilbad Heiligenstadt

42897

Hautarztpraxis Mortazawi /ID# 255872, Remscheid

R3M 3Z4

Wiseman Dermatology Research /ID# 255883, Winnipeg

L8N 1Y2

Dermatrials Research /ID# 253879, Hamilton

L3P 1X2

Lynde Institute for Dermatology /ID# 253876, Markham

K1H 7X3

JRB Research /ID# 253877, Ottawa

K9J 5K2

SKiN Centre for Dermatology /ID# 255882, Peterborough

J7Z 7E2

Dre Angelique Gagne-Henley M.D. inc. /ID# 262591, Saint-Jérôme

01109

Dermatologische Praxis Dr. med. Marvin Kuske /ID# 265688, Dresden

04317

Praxis Dres. Wiemers/Wiemers /ID# 255873, Leipzig

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY